The newest classes of diabetes meds to treat type 2 are pulling more than double duty, helping to better control blood sugars, protect the heart, lower body weight and prevent chronic kidney disease.
read more →SGLT-2 Inhibitors including Invokana (canagliflozin), Farxiga (dapagliflozin), Jardiance (empagliflozin) and Steglatro (ertugliflizin), are the newest class of oral medications for the treatment of type 2 diabetes. They’re generally well tolerated and associated with significant weight loss compared with other type 2 oral meds, but there are still precautions to consider.
read more →The use of DPP-4 inhibitors (Januvia, Onglyza, Tradjenta and Nesina) has been so widespread because these medications come in a pill, only need to be taken once a day and have few side effects.
read more →Insulin sensitizers represent an important class of oral medications for the treatment of type 2 diabetes and work mainly by reducing insulin resistance, but a false scare with rosiglitatone led to prescribing changes for many healthcare providers.
read more →Metformin is currently recommended as the first drug of choice for people with newly diagnosed type 2 diabetes (unless there is a contraindication to it) and is generally a safe medication. However, there are a few precautions to take and things to be aware of while on the medication.
read more →There are nine major types of oral medications in the U.S. for people living with type 2 diabetes. In this first article of a series, we’re focusing on sulfonylureas or SFUs, which are one of the oldest oral medications on the market.
read more →A new oral medication for T1D is awaiting FDA approval, and it’s shown fewer highs, fewer lows, and more predictable insulin dosing in recent studies.
read more →What happens when you accidentally inject yourself with a big dose of the wrong insulin? Author Sarah Durrand shares how an extreme low blood sugar led her to one of her highest achievements.
read more →Recently approved by the FDA, Ozempic sets itself apart from other once-weekly GLP-1 RAs for type 2 diabetes by demonstrating the quickest and greatest effect in reducing blood glucose and body weight in studies. Is it right for you?
read more →We all have them…mistakes we’ve made that we don’t even want to share with our own mother. Dr. Jeremy Pettus puts it all out there and gets real about what recently happened when he took the right dose of the wrong insulin.
read more →